Boehringer’s lung drug Spiriva, approved for chronic obstructive pulmonary disease (COPD) and asthma, generated net sales of 2.4 billion euros, down 11.4% compared with last year, which the ...

These can include chronic medications that manage symptoms of GERD, COPD, or CHF. Or it may involve a procedure ... They are also used as add-on therapy for asthma maintenance in the case of Spiriva.

AstraZeneca has rolled out a fresh TV spot for its blockbuster-to-be Breztri, hitting the me | AstraZeneca has rolled out a ...

The every-other-week injectable drug is now the first biologic therapy approved by the FDA for treating COPD. In COPD, damage to the lungs leads to inflamed airways that cause breathing difficulty ...

Early flooding hits Venice, Fla. Honda recalls nearly 1.7 million vehicles for steering problem that could lead to crashes ...

The U.S. Food and Drug Administration has approved Dupixent (dupilumab) to reduce COPD exacerbations in some patients whose symptoms aren’t adequately controlled with inhaled medicines.

Regeneron and Sanofi shares edged higher Friday after their drug to treat chronic obstructive pulmonary disease (COPD) received approval from the Food and Drug Administration (FDA). The drug ...

An approval in COPD has been viewed by Wall Street analysts as a way to meet those lofty projections. But the drug’s success in the disease wasn’t a sure thing, as biologics have historically ...

Oct. 2, 2024 — The FDA has approved Regeneron and Sanofi’s drug Dupixent for patients with COPD (chronic obstructive pulmonary disease). Marking the sixth indication for the drug, the approval ...

The drug was cleared for use in adults whose COPD symptoms aren’t under control and whose disease is driven by eosinophils, a type of immune cell that can contribute to inflammation. There are ...

COPD is a known risk factor for PE. To estimate how the obstructive lung disease may contribute to PE-related deaths among ...